Related Experiment Videos
Endothelium-derived vasoactive substances in Bartter's syndrome
1Institute of Internal Medicine, Division of Nephrology, University of Padova, Italy.
Angiology
|October 1, 1995
Summary
Bartter's syndrome is linked to vascular hyporeactivity due to an imbalance of endothelin and nitric oxide (NO). Elevated endothelin and increased nitric oxide (NO) synthesis contribute to this condition.
Area of Science:
- Vascular Biology
- Endocrinology
- Nephrology
Background:
- Vascular hyporeactivity may stem from an imbalance in endothelium-derived vasoactive substances.
- Endothelin and nitric oxide (NO) are key regulators of vascular tone.
- Bartter's syndrome is characterized by renal salt wasting and electrolyte disturbances.
Purpose of the Study:
- To investigate the roles of endothelin and nitric oxide (NO) in the vascular hyporeactivity observed in Bartter's syndrome.
- To determine if elevated endothelin and altered NO metabolism contribute to the vascular dysfunction in this condition.
Main Methods:
- Plasma endothelin levels were measured.
- Urinary excretion of NO2- and NO3- (markers of NO synthesis) was quantified.
- Forearm blood flow (FBF) responses, including resting FBF and post-ischemic recovery, were assessed.
Main Results:
- Patients with Bartter's syndrome exhibited significantly higher plasma endothelin levels compared to controls.
- Urinary NO2- and NO3- excretion were elevated in Bartter's syndrome patients, indicating increased NO synthesis.
- Higher resting forearm blood flow (FRBF) and a slower recovery of peak flow were observed in patients.
Conclusions:
- Elevated plasma endothelin in Bartter's syndrome supports its role in vascular reactivity defects.
- Increased nitric oxide (NO) synthesis, evidenced by higher urinary NO metabolites and FRBF, contributes to vascular hyporeactivity.
- The findings suggest a dual role for endothelin and NO in the vascular dysfunction associated with Bartter's syndrome.